Evidence map›Paper›PMID 41902255›Full record

ArticleViruses2026

Viral Suppression Among People Living with HIV in Tajikistan: A Nationwide Analysis.

Kamiar Alaei, Brian Kwan, Christopher P Lounsbery, Jamoliddin Abdullozoda, Salomudin J Yusufi, Patricia Cortez, Mannat Tiwana, Julie Nguyen, Hamid R Torabzadeh, Arash Alaei

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kamiar AlaeiDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.
Brian KwanDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.ORCID 0000-0002-5180-9219
Christopher P LounsberyDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.
Jamoliddin AbdullozodaMinistry of Health and Social Protection of the Population, Dushanbe 734025, Tajikistan.
Salomudin J YusufiFaculty of Pharmacology, Avicenna Tajik State Medical University, Dushanbe 734000, Tajikistan.
Patricia CortezDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.
Mannat TiwanaDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.ORCID 0009-0000-1594-4563
Julie NguyenDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.
Hamid R TorabzadehCenter for Global Health, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.ORCID 0009-0003-6446-6176
Arash AlaeiDepartment of Health Science, College of Health and Human Services, California State University Long Beach, Long Beach, CA 90840, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral suppression is a cornerstone of HIV management, essential for improving health outcomes and preventing transmission. However, varying definitions of suppression, ranging from ≤1000 copies/mL (controlled) to ≤200 (clinically suppressed) and ≤50 (untransmittable), complicate the assessment of progress toward global UNAIDS 95-95-95 goals. Our study evaluated progress in achieving viral suppression among people living with HIV (PLHIV) in Tajikistan between 2010 and 2024 using cross-sectional data from the Ministry of Health and Social Protection of Population registry. Viral load was measured using real-time PCR, and suppression was assessed across three thresholds (≤1000, ≤200, ≤50 copies/mL). We examined associations between viral suppression and demographic factors using Chi-square tests and logistic regression models. Across all thresholds, suppression rates remained below the UNAIDS 95-95-95 target goals. At the ≤50 copies/mL threshold, 77% of males and 83% of females achieved suppression, with males demonstrating lower odds of achieving viral suppression. Regional disparities were evident, with Khatlon and Sughd showing the lowest viral suppression rate (72.2% and 76.8%, respectively) and lower odds of achieving viral suppression compared to Dushanbe. Urban-rural differences were also observed (78.3% vs. 81.1%), though odds ratios using logistic regression models were not significant. Findings highlight persistent demographic and regional disparities, underscoring the need for targeted interventions to achieve equitable viral suppression in Tajikistan. Our findings also highlight associations and do not imply causal inference. In addition, authors acknowledge that interpretation of viral suppression outcomes is limited by the absence of data on treatment regimens, duration, adherence, CD4 counts, and behavioral factors.

Indexed as

Anti-HIV AgentsHIV InfectionsViral LoadAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedTajikistanAnti-HIV AgentsageCentral Asiagender disparityregional disparityrural areasTajikistanUNAIDSviral suppression

Identifiers

PMID41902255
PMCPMC13030861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.